Cargando…
Upregulation of lncRNA plasmacytoma variant translocation 1 predicts poor prognosis in patients with muscle-invasive bladder cancer
LncRNA plasmacytoma variant translocation 1 (PVT1) has been recognized as an oncogenic lncRNA, which participates in the migration and invasion of many kinds of cancer cells and the development of cancers. In the present study, we explored its clinical significance and prognostic value in muscle inv...
Autores principales: | Li, Bin, Guo, Li-hua, Ban, Zi-qin, Liu, Lu, Luo, Lei, Cui, Tong-yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360260/ https://www.ncbi.nlm.nih.gov/pubmed/32664121 http://dx.doi.org/10.1097/MD.0000000000021059 |
Ejemplares similares
-
LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma
por: Liu, Zhongyuan, et al.
Publicado: (2017) -
Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer
por: Zeng, Tao, et al.
Publicado: (2023) -
LncRNA HEIH expression in cancer prognosis: A review and meta-analysis
por: Wang, Xuhua, et al.
Publicado: (2023) -
Prognosis of solitary bone plasmacytoma of the extremities: A SEER-based study
por: Zhao, Renbo, et al.
Publicado: (2021) -
LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis
por: Wang, Xuhua, et al.
Publicado: (2022)